Gilead Sciences
GILD
1,528 hedge funds and large institutions have $79.3B invested in Gilead Sciences in 2018 Q3 according to their latest regulatory filings, with 91 funds opening new positions, 539 increasing their positions, 693 reducing their positions, and 72 closing their positions.
26% more first-time investments, than exits
New positions opened: 91 | Existing positions closed: 72
21% more funds holding in top 10
Funds holding in top 10: 47 → 57 (+10)
9% more capital invested
Capital invested by funds: $72.7B → $79.3B (+$6.6B)
0% more funds holding
Funds holding: 1,523 → 1,528 (+5)
0.31% more ownership
Funds ownership: 79% → 79.31% (+0.31%)
22% less repeat investments, than reductions
Existing positions increased: 539 | Existing positions reduced: 693
27% less call options, than puts
Call options by funds: $1.21B | Put options by funds: $1.66B
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Capital Research Global Investors
Los Angeles,
California
|
+$968M |
| 2 |
Skandinaviska Enskilda Banken (SEB)
Stockholm,
Sweden
|
+$224M |
| 3 |
Swedbank
Stockholm,
Sweden
|
+$150M |
| 4 |
TCIM
TIAA CREF Investment Management
New York
|
+$135M |
| 5 |
Renaissance Technologies
New York
|
+$131M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Parnassus Investments
San Francisco,
California
|
-$683M |
| 2 |
BlackRock
New York
|
-$245M |
| 3 |
American Century Companies
Kansas City,
Missouri
|
-$217M |
| 4 |
FCM
Farallon Capital Management
San Francisco,
California
|
-$207M |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$147M |
GILD Hedge Fund Activity: Q3 2018 in Review
1,528 of the 4,375 institutional investors tracked by Wall St. Rank reported a position in Gilead Sciences (GILD) for Q3 2018, worth a combined $79.3B — up 9.1% from $72.7B a quarter earlier.
Buyers outnumbered sellers: 91 funds opened new GILD positions and 72 closed out — a net gain of 19 holders — while 539 added to existing stakes and 693 trimmed.
The largest buyer was Capital Research Global Investors, adding an estimated $968M. The largest seller was Parnassus Investments, cutting an estimated $683M.
- 1,528 institutional investors held Gilead Sciences (GILD) as of Q3 2018, up from 1,523 in Q2 2018.
- Funds reported $79.3B of Gilead Sciences stock for Q3 2018, up 9.1% quarter-over-quarter.
- 91 funds opened new Gilead Sciences positions in Q3 2018 and 72 closed out, a net change of +19 holders.
- The largest Gilead Sciences buyer in Q3 2018 was Capital Research Global Investors, an estimated $968M added.
- The largest Gilead Sciences seller in Q3 2018 was Parnassus Investments, an estimated $683M sold.
Based on aggregated 13F filings for Q3 2018.